Canaan Partners X LLC, 10% Owner at Protagonist Therapeutics, Inc (PTGX), sold 40,730 shares at $20.51 ($837K) on 2018-03-16, disclosed to the SEC on 2018-03-19.
Open-market sale of $837k PTGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.51 | 6,926 | $142K | 17.0% |
| 2 | $20.51 | 6,926 | $142K | 17.0% |
| 3 | $20.57 | 13,439 | $276K | 33.0% |
| 4 | $20.57 | 13,439 | $276K | 33.0% |
| Total | $20.55 avg | 40,730 | $837K | 100% |
| Filing → |
| PTGX | SELL | 2018-03-26 | $2.5M | — | Filing → |
| PTGX | SELL | 2018-03-15 | $514K | — | Filing → |